Addex Therapeutics Ltd (ADXN) Stock Analysis

What Addex Therapeutics Ltd does

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves identifying oral small-molecule allosteric modulators for G-protein coupled receptors. The company's key programs include Dipraglurant, an investigational treatment for Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149, which is being developed for epilepsy and other unspecified CNS conditions; and GABAB PAM, a compound aimed at treating addiction. Addex Therapeutics has established licensing and collaboration agreements with significant partners, including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002 and based in Geneva, Switzerland, the company was initially known as Addex Pharmaceuticals Ltd before officially changing its name to Addex Therapeutics Ltd in March 2012.

Key metrics

ETFs linked to ADXN

Broad-market and Healthcare sector ETFs an investor holding Addex Therapeutics Ltd is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ADXN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Addex Therapeutics Ltd?

Addex Therapeutics Ltd trades under the ticker ADXN on NASDAQ.

Which exchange is ADXN listed on?

ADXN is listed on NASDAQ.

What sector does Addex Therapeutics Ltd operate in?

Addex Therapeutics Ltd is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ADXN in a portfolio?

PortView shows ADXN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.